AMGEN INC
AMGNAPI behind this page
AMGN FY 2025 request
Playground key active
/api/financials?ticker=AMGN&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.
Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 36,751 | 33,424 | +10.0% |
Show Product Lines breakouts |
|||
| Aranesp | 1,389 | 1,342 | +3.5% |
| Aranesp · Non Us | 973 | 956 | +1.8% |
| Aranesp · US | 416 | 386 | +7.8% |
| BeOne · BeOne | 266 | 259 | +2.7% |
| BLINCYTO | 1,559 | 1,216 | +28.2% |
| BLINCYTO · Non Us | 510 | 416 | +22.6% |
| BLINCYTO · US | 1,049 | 800 | +31.1% |
| ENBREL | 2,226 | 3,316 | -32.9% |
| ENBREL · Non Us | 27 | 28 | -3.6% |
| ENBREL · US | 2,199 | 3,288 | -33.1% |
| EVENITY | 2,100 | 1,563 | +34.4% |
| EVENITY · Non Us | 500 | 432 | +15.7% |
| EVENITY · US | 1,600 | 1,131 | +41.5% |
| KRYSTEXXA | 1,340 | 1,185 | +13.1% |
| KRYSTEXXA · US | 1,340 | 1,185 | +13.1% |
| KYPROLIS | 1,412 | 1,503 | -6.1% |
| KYPROLIS · Non Us | 499 | 555 | -10.1% |
| KYPROLIS · US | 913 | 948 | -3.7% |
| Nplate | 1,524 | 1,456 | +4.7% |
| Nplate · Non Us | 497 | 486 | +2.3% |
| Nplate · US | 1,027 | 970 | +5.9% |
| Otezla | 2,265 | 2,126 | +6.5% |
| Otezla · Non Us | 426 | 427 | -0.2% |
| Otezla · US | 1,839 | 1,699 | +8.2% |
| Other products | 7,263 | 5,630 | +29.0% |
| Other products · Non Us | 1,826 | 1,593 | +14.6% |
| Other products · US | 5,437 | 4,037 | +34.7% |
| Product | 35,148 | 32,026 | +9.7% |
| Product And Service Other | 1,603 | 1,398 | +14.7% |
| Product And Service Other · Non Us | 840 | 836 | +0.5% |
| Product And Service Other · US | 763 | 562 | +35.8% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | 10 | 192 | -94.8% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | 10 | 192 | -94.8% |
| Product · Cardinal Health, Inc. | 12,562 | 11,278 | +11.4% |
| Product · Cencora, Inc. | 20,986 | 18,387 | +14.1% |
| Product · McKesson Corporation | 26,253 | 22,173 | +18.4% |
| Product · Non Us | 9,492 | 8,725 | +8.8% |
| Product · US | 25,656 | 23,301 | +10.1% |
| Prolia | 4,414 | 4,374 | +0.9% |
| Prolia · Non Us | 1,436 | 1,489 | -3.6% |
| Prolia · US | 2,978 | 2,885 | +3.2% |
| Repatha | 3,016 | 2,222 | +35.7% |
| Repatha · Non Us | 1,353 | 1,083 | +24.9% |
| Repatha · US | 1,663 | 1,139 | +46.0% |
| TEPEZZA | 1,903 | 1,851 | +2.8% |
| TEPEZZA · Non Us | 145 | 16 | +806.2% |
| TEPEZZA · US | 1,758 | 1,835 | -4.2% |
| TEZSPIRE | 1,478 | 972 | +52.1% |
| TEZSPIRE · US | 1,478 | 972 | +52.1% |
| Vectibix | 1,175 | 1,045 | +12.4% |
| Vectibix · Non Us | 571 | 526 | +8.6% |
| Vectibix · US | 604 | 519 | +16.4% |
| XGEVA | 2,084 | 2,225 | -6.3% |
| XGEVA · Non Us | 729 | 718 | +1.5% |
| XGEVA · US | 1,355 | 1,507 | -10.1% |
Show Geography breakouts |
|||
| Non Us | 10,332 | 9,561 | +8.1% |
| US | 26,419 | 23,863 | +10.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 36,751 | 33,424 | +10.0% |
| Cost of Revenue | 12,037 | 12,858 | -6.4% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 9,845 | 11,118 | -11.4% |
| Research And Development Expense Excluding Acquired In Process Cost | 7,272 | 5,964 | +21.9% |
| Selling, General & Administrative | 7,050 | 7,096 | -0.6% |
| Other General Expense | 1,312 | 248 | +429.0% |
| Total Costs & Expenses | 27,671 | 26,166 | +5.8% |
| Operating Income | 9,080 | 7,258 | +25.1% |
| Interest Expense Debt | -2,755 | -3,155 | +12.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | -2,755 | -3,155 | +12.7% |
| Non-Operating Income (Expense) | 2,651 | 506 | +423.9% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contract gains (losses) | 221 | -75 | +394.7% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contract gains (losses) | 221 | -75 | +394.7% |
| Income Before Taxes | 8,976 | 4,609 | +94.7% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 231 | 117 | +97.4% |
| Income Tax Expense (Benefit) | 1,265 | 519 | +143.7% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 51 | 25 | +104.0% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 1,265 | 519 | +143.7% |
| Net Income | 7,711 | 4,090 | +88.5% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 180 | 92 | +95.7% |
| Retained Earnings | 7,711 | 4,090 | +88.5% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 7,711 | 4,090 | +88.5% |
| EPS (Basic) | 14.33 | 7.62 | +88.1% |
| EPS (Diluted) | 14.23 | 7.56 | +88.2% |
| Wtd Avg Shares (Basic) | 538 | 537 | +0.2% |
| Wtd Avg Shares (Diluted) | 542 | 541 | +0.2% |
| Sales & Marketing (FY) | — | — | — |
Show Consolidation Items breakouts |
|||
| Operating Segments | 4,590 | 4,713 | -2.6% |
| General & Administrative (FY) | — | — | — |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,460 | 2,383 | +3.2% |
| Interest Income | 408 | 510 | -20.0% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 408 | 510 | -20.0% |
| Comprehensive Income | 7,519 | 4,313 | +74.3% |
| Other Comprehensive Income | -192 | 223 | -186.1% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -192 | 223 | -186.1% |
| Depreciation And Amortization | 887 | 805 | +10.2% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 9,129 | 11,973 | -23.8% |
| Accounts Receivable | 9,570 | 6,782 | +41.1% |
| Inventory | 6,225 | 6,998 | -11.0% |
| Other Assets Current | 4,133 | 3,277 | +26.1% |
| Total Current Assets | 29,057 | 29,030 | +0.1% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 7,913 | 6,543 | +20.9% |
Show Geography breakouts |
|||
| PR | 1,273 | 1,174 | +8.4% |
| ROW | 1,452 | 1,213 | +19.7% |
| US | 5,188 | 4,156 | +24.8% |
| Goodwill | 18,680 | 18,637 | +0.2% |
| Other Non-Current Assets | 12,660 | 9,930 | +27.5% |
| Total Assets | 90,586 | 91,839 | -1.4% |
| Operating Lease Right-of-Use Assets | 602 | 557 | +8.1% |
| Intangible Assets | 21,566 | 26,639 | -19.0% |
Show Product Lines breakouts |
|||
| Otezla · Developed Technology Rights | 3.4 | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 21,051 | 26,017 | -19.1% |
| Licensing Agreements | 395 | 483 | -18.2% |
| R&D technology rights | 120 | 139 | -13.7% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 22,276 | 27,699 | -19.6% |
| Current Liabilities | |||
| Accounts Payable | 2,367 | 1,908 | +24.1% |
| Accrued Liabilities | 18,523 | 17,641 | +5.0% |
| Current Portion of Long-Term Debt | 4,599 | 3,550 | +29.5% |
| Total Current Liabilities | 25,489 | 23,099 | +10.3% |
| Non-Current Liabilities | |||
| Long-Term Debt | 50,005 | 56,549 | -11.6% |
| Deferred Tax Liabilities | 1,366 | 1,616 | -15.5% |
| Liability For Uncertain Tax Positions Noncurrent | 2,690 | 2,349 | +14.5% |
| Other Non-Current Liabilities | 2,378 | 2,349 | +1.2% |
| Long-Term Debt | 54,604 | 60,099 | -9.1% |
Show Long-Term Debt Type breakouts |
|||
| Notes Payable To Banks | 52.8 | 58.3 | -9.4% |
| Operating Lease Liabilities | 696 | 673 | +3.4% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 34,023 | 33,533 | +1.5% |
| Retained Earnings | -25,107 | -27,590 | +9.0% |
| Accumulated Other Comprehensive Income | -258 | -66 | -290.9% |
| Total Stockholders' Equity | 8,658 | 5,877 | +47.3% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -90 | 287 | -131.4% |
| Accumulated Other Comprehensive Income | -258 | -66 | -290.9% |
| Accumulated Translation Adjustment | -202 | -374 | +46.0% |
| Common Stock Including Additional Paid In Capital | 34,023 | 33,533 | +1.5% |
| Other | 34 | 21 | +61.9% |
| Retained Earnings | -25,107 | -27,590 | +9.0% |
| Total Liabilities & Equity | 90,586 | 91,839 | -1.4% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 5,167 | 5,592 | -7.6% |
| Impairment Of Intangible Assets Excluding Goodwill | 1,200 | 159 | +654.7% |
| Stock-Based Compensation | 494 | 530 | -6.8% |
| Deferred Income Taxes And Tax Credits | -721 | -1,228 | +41.3% |
| Unrealized Gain Loss On Investments | -2,064 | 159 | -1398.1% |
| Other Non-Cash Items | 149 | -177 | +184.2% |
| Change in Accounts Receivable | -2,676 | 441 | -706.8% |
| Change in Inventory | 886 | 2,532 | -65.0% |
| Increase Decrease In Other Operating Assets | -1,267 | -652 | -94.3% |
| Change in Accounts Payable | 428 | 312 | +37.2% |
| Increase Decrease In Accrued Income Taxes Payable | -2,068 | -1,011 | -104.5% |
| Increase Decrease In Noncurrent Tax Liability | 311 | -492 | +163.2% |
| Increase Decrease In Accrued Liabilities | 499 | 92 | +442.4% |
| Increase Decrease In Sales Incentives And Allowance | 2,065 | 1,194 | +72.9% |
| Increase Decrease In Other Operating Liabilities | -156 | -51 | -205.9% |
| Net Cash from Operations | 9,958 | 11,490 | -13.3% |
| Deferred Income Taxes | -700 | -1,238 | +43.5% |
| Investing Activities | |||
| Payments To Acquire Businesses Net Of Cash Acquired | -53 | — | — |
| Capital Expenditures | -1,858 | -1,096 | -69.5% |
| Other Investing Activities | -32 | 50 | -164.0% |
| Net Cash from Investing | -1,943 | -1,046 | -85.8% |
| Financing Activities | |||
| Payments Of Debt Extinguishment Costs | -683 | -659 | -3.6% |
| Repayments Of Long Term Debt | -5,000 | -3,600 | -38.9% |
Show Debt Instrument breakouts |
|||
| 3.125% notes due 2025 (3.125% 2025 Notes) · Notes Payable To Banks | -1 | — | — |
| 5.250% Notes Due 2025 · Notes Payable To Banks | -2 | — | — |
| 5.507% Notes Due 2026 · Notes Payable To Banks | -1.5 | — | — |
| Various Long-Term Notes · Notes Payable To Banks | -1 | -875 | +99.9% |
Show Long-Term Debt Type breakouts |
|||
| Notes Payable To Banks | -500 | -3.6 | -13788.9% |
| Payments Of Dividends Common Stock | -5,124 | -4,832 | -6.0% |
| Proceeds From Payments For Other Financing Activities | -52 | -124 | +58.1% |
| Net Cash from Financing | -10,859 | -9,415 | -15.3% |
| Supplemental | |||
| Income Taxes Paid | 4,300 | 2.9 | +148175.9% |
| Other Cash Flow | |||
| Net Change in Cash | -2,844 | 1,029 | -376.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9,129 | 11,973 | -23.8% |
Values in millions USD. Source: SEC EDGAR 10-K filing.